Landec Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Albert Bolles
- Full Time Employees
- 689
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 5201 Great America Pkwy Ste 232 Santa Clara CA United States of America 93455
- IPO Date
- Feb 16, 1996
- CIK
- 0001005286
- Website
- landec.com
- Similar Companies
- Business
- Landec Corporation (LNDC) now operates primarily as Lifecore Biomedical, Inc., a dedicated life sciences company specializing in the development and production of sterile injectable products for global pharmaceutical and medical device sectors. The company’s core operations involve the creation of premium pharmaceutical-grade sodium hyaluronate in bulk form, alongside the formulation and aseptic filling of syringes and vials for a range of injectable products utilized in treating various medical conditions and procedures. Lifecore Biomedical provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and the production of materials for clinical studies to its partners for both hyaluronate-based and other aseptically formulated and filled products. These offerings support medical applications predominantly in ophthalmic, orthopedic, and other specialized markets. Landec Corporation, originally established in 1986, has strategically divested its former food and packaging segments, including the Curation Foods business that previously marketed olive oils, wine vinegars, and avocado food items under various brands. The company’s primary operational hub is now located in Chaska, Minnesota.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
LFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Landec Corporation (LNDC) Q1 2023 Earnings Call Transcript
Landec (LNDC) Reports Q1 Loss, Tops Revenue Estimates
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT
7 Small-Cap Stocks to Buy Before September Ends
Landec Corporation (LNDC) CEO Jim Hall on Q4 2022 Results - Earnings Call Transcript
7 Small-Cap Stocks to Buy in July 2022
Landec Corporation (LNDC) CEO Albert Bolles on Q3 2022 Results - Earnings Call Transcript
Landec Corporation (LNDC) CEO Albert Bolles on Q2 2022 Results - Earnings Call Transcript
Landec (LNDC) Reports Q2 Loss, Misses Revenue Estimates
Earnings Preview: Landec (LNDC) Q2 Earnings Expected to Decline
Landec (LNDC) Stock Jumps 13%: Will It Continue to Soar?
Landec Closes Sale Of Curation Food's Fresh Packaged Salads, Vegetables Business
Optimistic About Landec's Strategic Initiatives And Sodium Hyaluronate Products
Why Landec Stock Crashed on Thursday